Hideaki Suzuki

Apr 29, 2024 | onlinelibrary.wiley.com | Hideaki Suzuki |Takumi Inoue |Yousuke Terui |Kouki Takeuchi

Introduction Increasing cyclic 3′,5′-guanosine monophosphate (cGMP) represents a unique therapeutic approach.

Oct 31, 2023 | onlinelibrary.wiley.com | Masashi Takeuchi |Hideaki Suzuki |Satoshi Miyata |Satoru Ebihara

Dear Editor, Transcatheter aortic valve implantation (TAVI) is a well-established treatment for aortic stenosis (AS) in older adults and/or patients with frailty, which leads to conventional symptoms, including angina and even death.1 Delirium after TAVI (DAT) occurs in up to 44% of patients and exacerbates long-term prognosis and healthcare burden.2 Preoperative cerebral blood flow (CBF) in the insula, whose dysfunction is associated with delirium,3 is lower in patients with DAT relative to...

Aug 22, 2023 | mdpi.com | Makoto Inoue |Hideaki Suzuki |Shan Liu |Kohji Meno

1. IntroductionLate-onset Alzheimer’s disease (AD), which develops in old age, interferes with daily life through cognitive decline in affected people aged ≥65 years. The pathophysiology of AD is a continuum, progressing from the preclinical phase, in which there are no clinical symptoms, to mild cognitive impairment (MCI) and impairment of daily life [1], and then to dementia.